Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Postoperative Urinary Retention (POUR)
In brief
The purpose of this research study is to determine if taking tamsulosin preoperatively decreases your chances of being discharged after surgery with a Foley catheter (flexible tube that drains urine from the bladder into a collection bag).
Key facts
- Study ID
- NCT06843538
- Run by
- TriHealth Inc.
- People needed
- 166
- Starts
- 2025-02-03
- Expected to finish
- 2026-06-01
- Last updated by the study team
- 2025-02-25
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Patients undergoing any pelvic organ prolapse repair or incontinence surgery
You may not qualify if…
- Any surgery involving a non-urogynecologist
- Patients already on an alpha blocker
- Baseline hypotension
- History of syncope
- Postural orthostatic tachycardia syndrome (POTS)
- Non-English speaker or interpreter unavailable for Spanish-speaking patient
- Impaired cognition impeding proper consenting
- Any other medical contraindication for tamsulosin use
- History of urinary retention requiring continuous or intermittent catheterization
- Patients consented for the study but then due to intraoperative complication, routine voiding trial no longer indicated due to requiring indwelling catheter or intermittent catheterization on discharge will be excluded from primary outcome analysis
- Pregnancy
Where it is running
- TriHealth — Cincinnati, Ohio, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.